Home/Filings/4/0001140361-25-042764
4//SEC Filing

Dillow Jason 4

Accession 0001140361-25-042764

CIK 0001612720other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 5:53 PM ET

Size

86.8 KB

Accession

0001140361-25-042764

Insider Transaction Report

Form 4
Period: 2025-11-17
Transactions
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
Transactions
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
Transactions
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
Transactions
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
Transactions
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
Transactions
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
Transactions
  • Disposition to Issuer

    Tranche C Warrants

    2025-11-17818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2030-05-14Common Stock (818,171 underlying)
  • Award

    Series A-2 Loans

    2025-11-17+452,059452,059 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (452,059 underlying)
  • Award

    Series A-1 Loans

    2025-11-17+1,587,9471,587,947 total(indirect: See notes)
    Exercise: $9.50From: 2025-11-17Exp: 2030-11-17Common Stock (1,587,947 underlying)
  • Award

    Tranche C Warrants

    2025-11-17+818,171818,171 total(indirect: See notes)
    Exercise: $9.30From: 2025-11-17Exp: 2032-05-14Common Stock (818,171 underlying)
Footnotes (7)
  • [F1]See Exhibit 99.1 for text of footnote (1).
  • [F2]See Exhibit 99.1 for text of footnote (2).
  • [F3]See Exhibit 99.1 for text of footnote (3).
  • [F4]See Exhibit 99.1 for text of footnote (4).
  • [F5]See Exhibit 99.1 for text of footnote (5).
  • [F6]See Exhibit 99.1 for text of footnote (6).
  • [F7]See Exhibit 99.1 for text of footnote (7).

Issuer

NextDecade Corp

CIK 0001612720

Entity typeother

Related Parties

1
  • filerCIK 0001713578

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:53 PM ET
Size
86.8 KB